ProfileGDS5678 / 1420779_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 57% 58% 58% 58% 58% 57% 55% 57% 57% 58% 57% 57% 57% 57% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.5138757
GSM967853U87-EV human glioblastoma xenograft - Control 23.4764858
GSM967854U87-EV human glioblastoma xenograft - Control 33.4768558
GSM967855U87-EV human glioblastoma xenograft - Control 43.450158
GSM967856U87-EV human glioblastoma xenograft - Control 53.4461758
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.5294357
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.4747655
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4519757
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4504457
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4670558
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4596357
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4336157
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4733257
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4658657